Literature DB >> 10369321

Prevalence of drugs used in cases of alleged sexual assault.

M A ElSohly1, S J Salamone.   

Abstract

In recent years, there has been an increase in the number of reports in the U.S. of the use of drugs, often in conjunction with alcohol, to commit sexual assault. A study was undertaken to assess the prevalence of drug use in sexual assault cases in which substances are suspected of being involved. Law enforcement agencies, emergency rooms, and rape crisis centers across the U.S. were offered the opportunity to submit urine samples collected from victims of alleged sexual assault, where drug use was suspected, for analysis of alcohol and drugs which may be associated with sexual assault. Each sample was tested by immunoassay for amphetamines, barbiturates, benzodiazepines, cocaine metabolite (benzoylecgonine), cannabinoids, methaqualone, opiates, phencyclidine and propoxyphene. The positive screen results were confirmed by gas chromatography-mass spectroscopy (GC-MS). In addition, each sample was tested for flunitrazepam metabolites and gamma-hydroxybutyrate (GHB) by GC-MS and for ethanol by gas chromatography-flame ionization detection (GC-FID). Over a 26-month period, 1179 samples were collected and analyzed from 49 states, Puerto Rico, and the District of Columbia. The states sending the most samples were California (183), Texas (119), Florida (61), Pennsylvania (61), New York (61), Minnesota (50), Illinois (47), Indiana (44), Michigan (40), Maryland (37), Virginia (32), and Massachusetts (31). Four-hundred sixty eight of the samples were found negative for all the substances tested; 451 were positive for ethanol, 218 for cannabinoids, 97 for benzoylecgonine, 97 for benzodiazepines, 51 for amphetamines, 48 for GHB, 25 for opiates, 17 for propoxyphene, and 12 for barbiturates. There were no samples identified as positive for phencyclidine or methaqualone. In addition, 35% of the drug-positive samples contained multiple drugs. This study indicates that, with respect to alleged sexual assault cases, the prevalence of ethanol is very high, followed by cannabinoids, cocaine, benzodiazepines, amphetamines, and GHB. Although only a couple of substances have been implicated with sexual assault, this study has shown that almost 20 different substances have been associated with this crime. This study also raises the concern of illicit and licit drug use in sexual assault cases and suggests the need to test for a range of drugs in these cases. It also highlights the need to test for GHB, which is not generally tested for in a normal toxicology screen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369321     DOI: 10.1093/jat/23.3.141

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  27 in total

Review 1.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

2.  Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.

Authors:  Ilene B Anderson; Susan Y Kim; Jo Ellen Dyer; Cindy B Burkhardt; Jayme C Iknoian; Michael J Walsh; Paul D Blanc
Journal:  Ann Emerg Med       Date:  2005-12-28       Impact factor: 5.721

3.  Chemical submission: results of 4-year French inquiry.

Authors:  S Djezzar; F Questel; E Burin; S Dally
Journal:  Int J Legal Med       Date:  2008-10-17       Impact factor: 2.686

4.  Designing a gamma hydroxybutyrate (GHB) structured telephone-administered survey instrument.

Authors:  Jo E Dyer; Ilene Anderson; Susan Kim; Paul Blanc; Judith Barker
Journal:  J Med Toxicol       Date:  2007-03

5.  Response to, "Cognitive, psychomotor and subjective effects of sodium oxybate and triazolam in healthy volunteers," 2009; 206(1):141-154.

Authors:  Deborah L Zvosec; Stephen W Smith
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

6.  GHB urine concentrations after single-dose administration in humans.

Authors:  Christine Haller; Dung Thai; Peyton Jacob; Jo Ellen Dyer
Journal:  J Anal Toxicol       Date:  2006 Jul-Aug       Impact factor: 3.367

7.  GHB-Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor.

Authors:  R Sircar; L-C Wu; K Reddy; D Sircar; A K Basak
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

8.  Analysis of clinical forensic examination reports on sexual assault.

Authors:  Stefanie Jänisch; Hildrun Meyer; Tanja Germerott; Urs-Vito Albrecht; Yvonne Schulz; Anette Solveig Debertin
Journal:  Int J Legal Med       Date:  2010-02-25       Impact factor: 2.686

9.  Digital Image Analysis for DETCHIP® Code Determination.

Authors:  Marcus Lyon; Mark V Wilson; Kerry A Rouhier; David J Symonsbergen; Kiran Bastola; Ishwor Thapa; Andrea E Holmes; Sharmin M Sikich; Abby Jackson
Journal:  Signal Image Process       Date:  2012-08

10.  Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.

Authors:  Evangelia Liakoni; Hallam Gugelmann; Delia A Dempsey; Timothy J Wiegand; Christopher Havel; Peyton Jacob; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2019-01-08       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.